Difference between revisions of "Adenosquamous carcinoma of the lung"

From Libre Pathology
Jump to navigation Jump to search
Line 1: Line 1:
'''Adenosquamous carcinoma of the lung''' is a rare epithelial derived [[malignancy]] of the [[lung]] with features of both [[adenocarcinoma of the lung|adenocarcinoma]] and [[squamous cell carcinoma of the lung|squamous cell carcinoma]].   
'''Adenosquamous carcinoma of the lung''', also '''lung adenosquamous carcinoma''', is a rare epithelial derived [[malignancy]] of the [[lung]] with features of both [[adenocarcinoma of the lung|adenocarcinoma]] and [[squamous cell carcinoma of the lung|squamous cell carcinoma]].   


It is grouped with the [[non-small cell lung cancer]]s.
It is grouped with the [[non-small cell lung cancer]]s.

Revision as of 01:49, 9 April 2014

Adenosquamous carcinoma of the lung, also lung adenosquamous carcinoma, is a rare epithelial derived malignancy of the lung with features of both adenocarcinoma and squamous cell carcinoma.

It is grouped with the non-small cell lung cancers.

General

Microscopic

Features:

  1. Adenocarcinoma component.
  2. Squamous cell carcinoma component.

See also

References

  1. Song, Z.; Lin, B.; Shao, L.; Zhang, Y. (Sep 2013). "Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma.". J Chin Med Assoc 76 (9): 481-5. doi:10.1016/j.jcma.2013.05.007. PMID 23769878.
  2. Iwanaga, K.; Sueoka-Aragane, N.; Nakamura, T.; Mori, D.; Kimura, S. (2012). "The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib.". Intern Med 51 (19): 2771-4. PMID 23037472.